findmyKOL

Dalvir Gill, MD

Basic profile

Interventional Cardiology

ORCIDNone on fileNPI↗
✓ Full record
RegionVincennes, IN · MidwestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Dalvir Gill is a Cardiology physician. OpenAlex indexes 47 publications with 455 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
47publications

Distinct works indexed by OpenAlex.

455citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
35companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

520 S 7th St
Vincennes, IN 475911038

Telephone

812-885-3243

Provider last certified this registry record 8 May 2023.

View the NPPES registry record

Industry payments

35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    80.1%
    Beta blocker19.3%
    Metoprolol Succinate78%Bisoprolol Fumarate14%Metoprolol Tartrate5%Carvedilol3%
    Part D<11 patients
    Statin13.7%
    Rosuvastatin Calcium57%Atorvastatin Calcium39%Pravastatin Sodium3%
    Part D<11 patients

    + 12 more classes in this area

  • Blood & clotting

    16.2%
    Factor Xa inhibitor7.6%
    Eliquis65%Xarelto35%
    Part D≥36 patients
    P2Y12 inhibitor7.4%
    Clopidogrel100%
    Part D≥85 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    3.3%
    SGLT2 inhibitor1.6%
    Jardiance63%Farxiga37%
    Part D<11 patients
    Potassium supplement1.2%
    Potassium Chloride100%
    Part D≥11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”